MOSCOW (Sputnik) – Russia’s Sputnik V vaccine’s efficiency in formation of cellular immunity to COVID-19 is close to 100 percent, a senior researcher at a genetic engineering laboratory of the Gamaleya institute said on Thursday.
MOSCOW (Sputnik) – Russia’s Sputnik V vaccine’s efficiency in formation of cellular immunity to COVID-19 is close to 100 percent, a senior researcher at a genetic engineering laboratory of the Gamaleya institute said on Thursday.
